These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26567956)

  • 21. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole Genome Amplification in Genomic Analysis of Single Circulating Tumor Cells.
    Gasch C; Pantel K; Riethdorf S
    Methods Mol Biol; 2015; 1347():221-32. PubMed ID: 26374320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of circulating tumour cells-biology and biomarkers.
    Krebs MG; Metcalf RL; Carter L; Brady G; Blackhall FH; Dive C
    Nat Rev Clin Oncol; 2014 Mar; 11(3):129-44. PubMed ID: 24445517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cells in precision medicine: challenges and opportunities.
    Rupp B; Ball H; Wuchu F; Nagrath D; Nagrath S
    Trends Pharmacol Sci; 2022 May; 43(5):378-391. PubMed ID: 35272862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular profiling of single circulating tumor cells with diagnostic intention.
    Polzer B; Medoro G; Pasch S; Fontana F; Zorzino L; Pestka A; Andergassen U; Meier-Stiegen F; Czyz ZT; Alberter B; Treitschke S; Schamberger T; Sergio M; Bregola G; Doffini A; Gianni S; Calanca A; Signorini G; Bolognesi C; Hartmann A; Fasching PA; Sandri MT; Rack B; Fehm T; Giorgini G; Manaresi N; Klein CA
    EMBO Mol Med; 2014 Nov; 6(11):1371-86. PubMed ID: 25358515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RareCyte® platform for next-generation analysis of circulating tumor cells.
    Kaldjian EP; Ramirez AB; Sun Y; Campton DE; Werbin JL; Varshavskaya P; Quarre S; George T; Madan A; Blau CA; Seubert R
    Cytometry A; 2018 Dec; 93(12):1220-1225. PubMed ID: 30277660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
    Joosse SA; Pantel K
    Cancer Metastasis Rev; 2016 Mar; 35(1):41-8. PubMed ID: 26931653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fourier Ptychographic Microscopy for Rapid, High-Resolution Imaging of Circulating Tumor Cells Enriched by Microfiltration.
    Williams A; Chung J; Yang C; Cote RJ
    Methods Mol Biol; 2017; 1634():107-117. PubMed ID: 28819844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating tumor cell isolation and diagnostics: toward routine clinical use.
    van de Stolpe A; Pantel K; Sleijfer S; Terstappen LW; den Toonder JM
    Cancer Res; 2011 Sep; 71(18):5955-60. PubMed ID: 21896640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay.
    Alix-Panabières C; Pantel K
    Expert Rev Mol Diagn; 2015; 15(11):1411-7. PubMed ID: 26390240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.
    Soekmadji C; Corcoran NM; Oleinikova I; Jovanovic L; ; Ramm GA; Nelson CC; Jenster G; Russell PJ
    Prostate; 2017 Oct; 77(14):1416-1423. PubMed ID: 28856701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic technologies for circulating tumour cells and exosomes.
    Shao H; Chung J; Issadore D
    Biosci Rep; 2015 Nov; 36(1):e00292. PubMed ID: 26604322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases.
    Mamdouhi T; Twomey JD; McSweeney KM; Zhang B
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):297-305. PubMed ID: 31053984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor heterogeneity and circulating tumor cells.
    Zhang C; Guan Y; Sun Y; Ai D; Guo Q
    Cancer Lett; 2016 May; 374(2):216-23. PubMed ID: 26902424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Molecular Voyage: Multiomics Insights into Circulating Tumor Cells.
    Zhang YW; Gvozdenovic A; Aceto N
    Cancer Discov; 2024 Jun; 14(6):920-933. PubMed ID: 38581442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cells: liquid biopsy of cancer.
    Alix-Panabières C; Pantel K
    Clin Chem; 2013 Jan; 59(1):110-8. PubMed ID: 23014601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.